Three known iridoid glycosides, antirrhide (1), antirrhinoside (2), and 5-O-β-allosylantirrhinoside (3), and two known flavone glycosides, linariin (4"'-O-acetylpectolinarin) (4) and linarin (acacetin-7-O-β-D-rutinoside) (5) were isolated from Linaria kurdica Boiss & Hohen. subsp. eriocalyx The structures of the isolated compounds were established from spectroscopic evidence. Compounds 1-3 showed high inhibitory potential against α-glucosidase.
No phytochemical study of L. kurdica subsp. eriocalyx has been reported previously. In this first work, we have isolated three iridoids (1) (2) (3) , together with two flavone glycosides (4) (5) . The structures of the compounds were established as antirrhide (1) [2, 16] , antirrhinoside (2) [2, 3, 16] , 5-O-β-allosylantirrhinoside (3) [9] , linariin (4) [6] and linarin (5) [6, 17] from spectroscopic and spectrometric data (1D NMR, and HRESIMS) and by comparison with literature data. Non-insulin dependent diabetes mellitus (NIDDM) is a heterogeneous disease resulting from a dynamic interaction between defects in insulin secretion and insulin action. The long term manifestation of this disease can result in the development of vascular disorders such as retinopathy, neuropathy and angiopathy. In recent years, many plants have been screened for their antidiabetic potential [18] . Some polysaccharides, peptides, alkaloids, glycopeptides, triterpenoids, amino acids, steroids, xanthenes, flavonoids, lipids, phenolics, coumarins, iridoids, alkyl disulfides, inorganic ions and guanidines have been reported to have antidiabetic activity with a variety of mechanisms [19] . Among the therapeutic drugs to prevent high blood glucose levels are inhibitors of α-glucosidase (EC 3.2.1.20), which is a membrane bound enzyme on the epithelium of the small intestine. This enzyme catalyzes the cleavage of glucose from disaccharides, impeding digestion and absorption of glucose from the gastrointestinal tract.
In this study, α-glucosidase inhibitory activity of compounds 1-5 from L. kurdica subsp. eriocalyx is reported for the first time using an in vitro model. Preliminary characterization of α-glucosidase inhibition was evaluated by the specific inhibitory activity of the compounds ( Table 1) .
The inhibitory profile demonstrated that of the five isolated compounds, iridoid glycosides (1-3) showed significant inhibitory effect on α-glucosidase comparable with the positive control, acarbose. Although flavonoids are well known α-glucosidase inhibitors and are claimed to have a crucial role in antidiabetic medicinal plants [20] , the flavone diglycosides 4 and 5 surprisingly had low inhibitory activities. Based on the most specific inhibitory effect, compounds 1-3 were selected for further investigation to determine their IC 50 values commonly used as a measure of inhibitory effectiveness ( Table 2 ).
The inhibitory potency of the selected compounds against the yeast α-glucosidase was higher than that of the therapeutic drug, acarbose. Antirrhide was the strongest enzyme inhibitor with an IC 50 value of 0.14 + 0.02 mg/mL compared to antirrhinoside (0.19 ± 0.03), 5-O-β-allosylantirrhinoside (0.19 ± 0.02), and acarbose (0.39 ± 0.015). Compounds 1-3 exhibited dosedependent inhibitory activities.
Most of the α-glucosidase inhibitors are sugars or derivatives of sugar moieties and they act by mimicking the pyranosyl moiety [20] . Interestingly, the isolated flavonoids including a disaccharide unit (α-rhamnose-1 6-β-glucose) (4 and 5) were less active than the mono-(1 and 2) and disaccharidic (3) iridoids, implying that not only the presence of a pyranosyl unit, but also the nature of the aglycone play an important role in antidiabetic activity.
Further studies are warranted to investigate the inhibitory behavior and pattern of the tested compounds on mammalian α-glucosidase. Then their potential for therapeutic use in prevention and treatment of hyperglycemia and diabetes mellitus should be confirmed by in vivo studies. 
Experimental

Extraction and isolation:
Air-dried and powdered plant material (whole plant, 260 g) was extracted with MeOH (2 x 1.5 L) at room temperature. The methanolic extract was evaporated under vacuum. The residue (30 g) was dissolved in water and then partitioned successively with n-hexane (4 x 100 mL), CH 2 Cl 2 (4 x 100 mL), and n-BuOH saturated with H 2 O (4 x 100 mL). The n-BuOH phase (12 g) was chromatographed by CC (silica gel, Merck. 7734, 800g, 6 x 120) using a stepgradient of CH 2 Cl 2 -MeOH mixtures (9:1, 8:2, 7:3) to give 2263 fractions (2.5 mL/fractions), which were combined into 44 main groups based on their TLC profiles. The residue obtained from fractions 603-658 (158.7 mg) gave a yellow precipitate, which was redissolved in MeOH and, after filtration, gave pure α-Glucosidase inhibitory activity of compounds from L. kurdica Natural Product Communications Vol. 5 (6) α-Glucosidase inhibition assay: α-Glucosidase from baker's yeast was prepared as follows. Wet Baker's yeast Özyuva (Adana, Turkey) was homogenized in 2 volumes of 50 mM phosphate buffer, pH 7.0. After centrifuging at 10.000 g for 10 min, the resulting supernatant (1.41 Unit/mg protein) was kept for assays. The inhibitory activities were assayed by the microplate method with partial modifications [21] . Briefly, to each 96-well microtiter plate, 10 μL of α-glucosidase in phosphate buffer (pH 7.0), 10 μL of test compound (differing concentrations) and 60 μL of buffer were added and pre-incubated at 37°C for 10 min. The reaction was started with the addition of 20 μL p-nitrophenyl-α-D-glucopyranoside (PNPG; 1 mM in total volume). The mixture was incubated for an additional 15 mins and then the reaction was stopped by adding 100 μL of 0.5 M Tris solution. The absorbance of p-nitrophenol released from PNPG at 405 nm was measured with a microplate spectrophotometer (Multiskan FC, Thermo Scientific). Controls without compounds were checked also as a reference. For all tests, the inhibition assay was performed in triplicate. The positive control was Acorbose (Glukobay, Bayer, Germany), which is a standard anti-diabetic drug. One unit of specific inhibitory activity was defined as the amount of inhibitor (compound) needed to inhibit one unit of enzyme activity. Inhibitory ratio was calculated as follows; inhibition (%) = 1 -(Activity sample / Activity control ) x 100.
Estimation of IC 50 values:
The concentration of the test compounds that inhibited the hydrolysis of PNPG by yeast α-glucosidase by 50% were determined by monitoring the inhibition effect of increasing concentrations of these compounds in the assays. The IC 50 value was determined by linear regression of the dose-response curves.
